Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »
Reset 

Aurora Cannabis Prepared for Expansion of Canada's Cannabis Market

Efficient distribution, new partnerships and a broad range of high-margin products
to be launched in major consumer markets

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2019

Zealand Pharma introduces new website to support people living with short bowel syndrome

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019
Related companies:  Zealand Pharma A/S

AgraFlora Organics Secures 51,500 Sq. Ft Edibles Manufacturing Facility; Anticipates Q1 2020 Receipt of Health Canada Sales and Processing Licenses

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019

German Federal Joint Committee (G-BA) Issues Exclusive Nationwide Reimbursement Decision for Oncotype DX Breast Recurrence Score® Test

Reimbursement Decision Follows IQWiG's Recommendation Based on TAILORx Study Results

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2019

Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference

SEATTLE, Wash. and VANCOUVER, British Columbia, June 21, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced that an abstract featuring data from the Phase 2b ORCA-1 trial has been accepted for... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  Achieve Life Sciences,Inc.

Sales of Hormone Replacement Therapy Products Set to Augment With Enhanced Government Support, Reports Fact.MR Study

ROCKVILLE, Maryland, June 21, 2019 /PRNewswire/ -- Based on the recently published Fact.MR report titled "Hormone Replacement Therapy Market Forecast, Trend Analysis & Competition Tracking... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

Bone Therapeutics SA: Information on the total number of voting rights and shares

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019

ObsEva SA to Present Nolasiban and Linzagolix Clinical Data at the ESHRE Annual Meeting June 23-26 in Vienna

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019
Related companies:  ObsEva SA

Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019

WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing

WUXI, China, June 20, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it planned to expand the new state-of-the-art... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  WuXi Biologics

Karo Pharma Acquires Trimb for MSEK 3,400 and Intends to Carry out a Rights Issue of Approximately MSEK 1,500

STOCKHOLM, June 20, 2019 /PRNewswire/ -- Karo Pharma AB (publ) (the "Company" or "Karo Pharma") has today acquired all the shares of Trimb Holding AB ("Trimb") from Avista Capital Partners ("Avista") and other shareholders for MSEK 3,400 (the "Transaction").... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  Karo Pharma AB

Invitae Reports Inducement Grants Under NYSE Rule 303A.08 to Former Employees of Singular Bio, Inc. in Connection with Closing of Acquisition

SAN FRANCISCO, June 20, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  Invitae Corporation

Regeneron and Sanofi Announce Positive Topline Phase 2 Results for IL-33 Antibody in Asthma

TARRYTOWN, N.Y. and PARIS, June 21, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  Regeneron Pharmaceuticals, Inc.

Family Research Council Celebrates Court Win for New Title X Rule, Calls it Important Step toward Ending Title X's Forced Partnership with the Abortion Industry

WASHINGTON, June 20, 2019 /PRNewswire/ -- The U.S. Court of Appeals for the Ninth Circuit just ruled that the Trump administration's regulations governing the Title X family planning program can go into effect while court proceedings play out. The Protect Life Rule at issue in this case... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

Global Fosfluconazole (CAS 194798-83-9) Market Report 2019: Focus on Manufacturers and Distributors

DUBLIN, June 20, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

Warrior Centric Health Awarded a Supplier Services Agreement for Veteran Population Health Services from Vizient, Inc.

ELLICOTT CITY, Md., June 20, 2019 /PRNewswire/ -- Warrior Centric Health (WCH)(┬«) announces an agreement... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  Vizient, Inc.

Medical Packaging Market Outlook to 2027: Growing Demand for Flexible Packaging Solutions

DUBLIN, June 20, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

Botulinum Toxin Market Value to Hit $8.5 Billion by 2025: Global Market Insights, Inc.

SELBYVILLE, Del., June 20, 2019 /PRNewswire/ -- U.S. botulinum toxin market held majority share of 95% in 2018. Rising prevalence of medical conditions such as chronic migraine, cervical dystonia, muscle spasticity etc. will boost market growth. Moreover, presence of major industry players coupled... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

Canopy Growth Corporation reports fourth quarter and fiscal 2019 results with annual sales of $226.3M

SMITHS FALLS, ON, June 20, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) today announced its financial results for the fourth quarter and fiscal year ended March 31, 2019. The audited Consolidated Financial Statements and Management's Discussion... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

Galapagos increases share capital through warrant exercises

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Galapagos NV
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »
to the top ↑